PharmiWeb.com - Global Pharma News & Resources

Clinical research - Press Releases

Date Title Company
14-Feb-2020 Regeneron’s therapeutic candidate for rare cholesterol disease expected to face pricing pressure, says GlobalData GlobalData
14-Feb-2020 Corrected Press Release: XBiotech Announces Preliminary Results of Tender Offer XBiotech
14-Feb-2020 New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) Janssen Pharmaceutical Companies of Johnson & Johnson
14-Feb-2020 Verona Pharma Announces Publication of Key Phase 2b COPD Data in Respiratory Research Verona Pharma
14-Feb-2020 New Insights on Mechlorethamine/Chlormethine gel presented at 4th World Congress of Cutaneous Lymphomas Helsinn Group
14-Feb-2020 New Phase 3b Interim Data from STARDUST Study Show Two-Thirds of Patients with Moderately to Severely Active Crohn’s Disease Achieved Clinical Remission After Two Doses of STELARA® (ustekinumab) Janssen
13-Feb-2020 Launch of innovative medical food provides a palatable new option for people diagnosed with rare metabolic disorder in the UK Galen
13-Feb-2020 BioNTech Announces Commencement of Public Offering of American Depositary Shares BioNTech
13-Feb-2020 RauCon Pharma Partnering Conferences Limit Attendance For More Value RauCon GmbH & Co
13-Feb-2020 Takeda Demonstrates Ongoing Commitment in Rare Hematology By Continuing to Gather Real-World Evidence and Advance Personalized Treatment Takeda Pharmaceutical Company
13-Feb-2020 Innovative – Compliant – Trusted: Copley marks a new decade with a major rebrand and a new product range. Copley Scientifi
13-Feb-2020 ‘Genetic rewiring’ drives cancer’s drug resistance The Institute of Cancer Research
13-Feb-2020 Abeona Therapeutics Announces Positive Interim Data from MPS III Gene Therapy Programs Presented at WORLDSymposium™ Abeona Therapeutics Inc.
13-Feb-2020 Sosei Heptares Operational HighlightsSosei Heptares Operational Highlights and Consolidated Results for the 12 Months ended 31 December 2019 and Consolidated Results for the 12 Months ended 31 December 2019 Sosei Heptares
13-Feb-2020 First patient dosed in pivotal phase 3 trial of SNF472 in calciphylaxis Sanifit
13-Feb-2020 The Alliance for Regenerative Medicine Releases Agenda for 2020 Cell & Gene Meeting on the Mediterranean Alliance for Regenerative Medicine
13-Feb-2020 New gene mutation associated with Fabry cardiomyopathy University of Eastern Finland
13-Feb-2020 SCTM roadmap and committed funding will boost Australia’s position in Asia-Pacific stem cell research landscape, says GlobalData GlobalData
13-Feb-2020 New genetic sequencing platform sheds more light on how a household antibacterial kills bacteria Quadram Institute and University of East Anglia
13-Feb-2020 Improvements welcome but NHS 'not out of the woods', says NHS Confederation NHS